HK Stock Market Move | Nexchip Semiconductor Corporation (02249) rose over 3%. The company's 28nm logic process platform has entered customer sample tape-out validation.
Nexchip Semiconductor Corporation (02249) rose over 3%, up 2.85% as of press time, at HK$26.76, with a turnover of HK$17.9199 million.
Nexchip Semiconductor Corporation (02249) rose over 3%, up 2.85% as of press time, at HK$26.76, with a turnover of HK$17.9199 million.
On the news front, recently, at the STAR Market 2026 semi-annual collective earnings briefing for the semiconductor manufacturing, equipment, and materials industries, Nexchip Semiconductor Corporation stated that its 28nm logic process platform has entered customer sample tape-out validation, and optimization of various process performance indicators is currently underway.
Huachuang Securities pointed out that Nexchip Semiconductor Corporation's 28nm logic process platform has entered customer sample tape-out validation, and 22nm logic chip process development is underway. In terms of process nodes, in the first half of 2026, the proportions of 55nm and below, 90nm, 110nm, and 150nm in the company's main business revenue were 14.29%, 39.38%, 26.72%, and 19.61%, respectively. The firm believes that the company's multi-process, multi-platform layout is expected to provide a solid foundation for future performance growth.
Related Articles

Citi: Raises PRADA (01913) target price to HK$41.5, maintains "Neutral" rating.

Amoy Diagnostics (300685.SZ) related products obtained IVDR CE certification.

Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice
Citi: Raises PRADA (01913) target price to HK$41.5, maintains "Neutral" rating.

Amoy Diagnostics (300685.SZ) related products obtained IVDR CE certification.

Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice

RECOMMEND





